MedTrace Logo

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

NCT00283283 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1316

Last updated 2021-02-12

Study results available
· View outcomes & findings →

Summary

This study compared full-dose Flu vaccine to half-dose Flu-vaccine during the 2004-2005 flu season.

Conditions

Interventions

BIOLOGICAL

Fluzone® (Aventis Pasteur inactivated influenza vaccine)

A/H1N1, A/New Caledonia/20/99; A/H3N2, A/Fujian/411/2002; B, B/Shanghai/361/2002

Sponsors & Collaborators

  • Walter Reed Army Medical Center

    collaborator FED

  • United States Army Medical Materiel Development Activity

    collaborator FED

  • Centers for Disease Control and Prevention

    collaborator FED

  • Uniformed Services University of the Health Sciences

    collaborator FED

  • Walter Reed Army Institute of Research (WRAIR)

    collaborator FED

  • U.S. Air Force Office of the Surgeon General

    collaborator FED

  • U.S. Army Medical Research and Development Command

    lead FED

Principal Investigators

  • Renata J Engler, M.D · Walter Reed Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2004-11-30
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00283283 on ClinicalTrials.gov